Role of Genetics in Post Thrombolysis Patients (RTPA); Targeting Optimal Thrombolysis Outcomes Study
Lead PI: Prof Chris Levi
No. of Patients Currently Recruited: 200 No. of Patients Required: 300
TOTO is collecting biological samples, imaging and clinical data to examine predictors of stroke outcome, particularly in patients who undergo thrombolysis or thrombectomy. The biological samples consist of serum, plasma and genetic material collected both before and after acute therapy, and in some cases, clots retrieved via thrombectomy.